Norepinephrine Refractory Vasoplegic Shock clinical trials

Explore recruiting norepinephrine refractory vasoplegic shock clinical trials.

Recruiting norepinephrine refractory vasoplegic shock studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Norepinephrine Refractory Vasoplegic Shock trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic shock: a multicentric randomized, double-blind placebo-controlled superiority trial : Vaso²R

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Norepinephrine Refractory Vasoplegic Shock trials by city

Norepinephrine Refractory Vasoplegic Shock in Toronto Norepinephrine Refractory Vasoplegic Shock in Vancouver Norepinephrine Refractory Vasoplegic Shock in Montreal Norepinephrine Refractory Vasoplegic Shock in Calgary Norepinephrine Refractory Vasoplegic Shock in Edmonton Norepinephrine Refractory Vasoplegic Shock in Ottawa Norepinephrine Refractory Vasoplegic Shock in Winnipeg Norepinephrine Refractory Vasoplegic Shock in Quebec City Norepinephrine Refractory Vasoplegic Shock in Hamilton Norepinephrine Refractory Vasoplegic Shock in Kitchener Norepinephrine Refractory Vasoplegic Shock in London Norepinephrine Refractory Vasoplegic Shock in Halifax Norepinephrine Refractory Vasoplegic Shock in New York Norepinephrine Refractory Vasoplegic Shock in Los Angeles Norepinephrine Refractory Vasoplegic Shock in Chicago Norepinephrine Refractory Vasoplegic Shock in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease